Hossein Hemmatazad
Papers
3
Total Citations
14
H-Index
2
About
Hossein Hemmatazad is a medical physicist whose research focuses on advancing stereotactic body radiation therapy (SBRT) and stereotactic radiosurgery (SRS), particularly for complex cases involving spinal and cranial tumors. His major contributions lie in evaluating the feasibility and dosimetric quality of cutting-edge radiotherapy techniques. Notably, his 2022 study on postoperative spine SBRT for patients with carbon fiber and titanium hybrid implants demonstrated that the CyberKnife robotic system can deliver safe, effective treatment near these challenging materials, a finding with significant clinical implications for spinal oncology. This work has garnered 10 citations, reflecting its practical impact. Hemmatazad has also compared the performance of the InCise 2 multi-leaf collimator (MLC) against the IRIS collimator for brain and liver tumors, providing critical data on plan quality for small and large targets. Through these studies, he has helped refine treatment planning for robotic radiotherapy, improving outcomes for patients with implants and deep-seated tumors. His work bridges the gap between advanced technology and real-world clinical application, making him a valuable contributor to the field of radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3